"IGG is a regional medical practice comprised of board certified private practice gastroenterologists and allied professionals. We are dedicated to improving the health of our patients by providing the highest quality gastrointestinal care utilizing evidence-based medicine in a safe, compassionate manner, following clinical standards as determined by available scientific knowledge, best practice and innovative treatment."

During the past decade, Northwest Gastroenterologists, S.C. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Gastroenterologists, S.C." #1 sponsor was "Abbott" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Gastroenterologists, S.C." #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Gastroenterologists, S.C." are "Crohn's Disease" (10 trials), "Ulcerative Colitis" (2 trials), "Colitis, Ulcerative" (1 trials) and "Irritable Bowel Syndrome" (1 trials). Many other conditions were trialed in "Northwest Gastroenterologists, S.C." in a lesser frequency.

Most popular intervention types in "Northwest Gastroenterologists, S.C." are "Drug" (10 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Filgotinib" (2 trials), "5 ASA, enemas, suppositories, corticosteroids" (1 trials), "Adalimumab (D2E7)" (1 trials) and "Adalimumab 40 mg eow or ew" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Gastroenterologists, S.C." are 14 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Gastroenterologists, S.C.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Northwest Gastroenterologists, S.C., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Gastroenterologists, S.C., 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".